ASTELLAS PHARMA UNSP.ADR (YPHA) — Defensive Interval Ratio
ASTELLAS PHARMA UNSP.ADR (YPHA) has a Defensive Interval Ratio of 228 days as of March 2025. Defensive assets of €662.47 Billion (cash €-, short-term investments €29.94 Billion, receivables €632.52 Billion) cover 228 days of daily cash needs of €2.91 Billion/day. Check YPHA tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
ASTELLAS PHARMA UNSP.ADR Defensive Interval Ratio (2022–2025)
This chart shows how ASTELLAS PHARMA UNSP.ADR's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of March 2025, the ratio stands at 228 days, meaning defensive assets of €662.47 Billion can fund 228 days of operations without new revenue. Also explore YPHA year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for ASTELLAS PHARMA UNSP.ADR (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for ASTELLAS PHARMA UNSP.ADR from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see how much is ASTELLAS PHARMA UNSP.ADR worth.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 228 days | €662.47 Billion | €2.91 Billion/day | €- | €29.94 Billion | ▲ +68 days |
| 2024 | 160 days | €563.77 Billion | €3.52 Billion/day | €- | €28.78 Billion | ▼ -65 days |
| 2023 | 225 days | €447.75 Billion | €1.99 Billion/day | €- | €19.78 Billion | ▲ +11 days |
| 2022 | 214 days | €403.76 Billion | €1.88 Billion/day | €- | €21.30 Billion | — |